LOADING
Comparing Merck & Company (MRK) and Salesforce Inc (CRM) across the Health Care and Technology sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | MRK | CRM |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | -- | $142.2B |
| P/E Ratio | -- | 20.1 |
| Forward P/E | -- | 12.0 |
| PEG Ratio | -- | 0.68 |
| EPS | -- | $8.62 |
| Revenue Growth (YoY) | -- | 13.3% |
| Profit Margin | -- | 18.7% |
| Return on Equity | -- | 16.9% |
| Dividend Yield | -- | 1.03% |
| Beta | -- | 1.18 |
| 52-Week High | -- | $267.75 |
| 52-Week Low | -- | $146.32 |
| Volume | -- | -- |